Loading…

LECONSAN - Owned by Medoncare Pharmaceutical Co., Ltd. - (Class 035) | Sealvo

Home Search: LECONSANLECONSAN #97196528

Updated Oct 5, 2026·31 searches this week

View on USPTO TSDR Find similar marks

LEC

USPTO Trademark Record

ABANDONED

LECONSAN

SN 97196528·Reg 0·Filed Dec 30, 2021

Owner Medoncare Pharmaceutical Co., Ltd.

Advertising; business management, organization and administration; office functions.

LECONSAN (Serial No. 97196528), Registration No. 0, is a abandoned US trademark filed on Dec 30, 2021 by Medoncare Pharmaceutical Co., Ltd.. This trademark covers Class 035 (Advertising, business management & retail services).

Mark Intelligence

LECONSAN (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 035 (Advertising, business management & retail services). Goods and services include Advertising; business management, organization and administration; office functions.. The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 30, 2021

SERIAL

97196528

REG#

0

Filing Information

StatusABANDONED

Filing DateDec 30, 2021

Serial Number97196528

Registration No.0

Status DateAug 14, 2023

Published for OppositionNov 15, 2022

Mark TypeDesign with words

Full Goods & Services

CLASSES

1

OFFICE

USPTO

COUNTRY

US

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

11 events

ABANDONMENT - NO USE STATEMENT FILED

Aug 14, 2023

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 14, 2023

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 10, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 15, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 15, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 26, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 11, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Oct 05, 2022

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 06, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 05, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 03, 2022

NEW APPLICATION ENTERED

Other Marks by Medoncare Pharmaceutical Co., Ltd.

Additional USPTO filings from the same owner.

SYN-NAT

88912528

Medoncare Pharmaceutical Co., Ltd.

LECONSAN

97196526

Medoncare Pharmaceutical Co., Ltd.

LECONVIN

87931502

Medoncare Pharmaceutical Co., Ltd.

SYN-NAT

87931684

Medoncare Pharmaceutical Co., Ltd.

Other Marks by Nazly Aileen Bayramoglu

Additional USPTO filings handled by the same attorney of record.

WINTEMP

88307031

ENOLA GAYE

88877361

XIAMENAIR

79147033

VERO MONTE

86832918